Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - FREUND JOHN GORDON
Last Updated 
30-Oct-14
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

FREUND JOHN GORDON: Declared Holdings
Company/RelationshipReportedShares  Ownership
Concert Pharmaceuticals, Inc.
Director
NasdaqGM:CNCE
(historical quotes, profile, other insiders)
20-Feb-141,208,920  Indirect
MAKO Surgical Corp.
Director
NasdaqGS:MAKO
(historical quotes, profile, other insiders)
17-Dec-130  Indirect
Proteon Therapeutics, Inc.
Director
NasdaqGM:PRTO
(historical quotes, profile, other insiders)
27-Oct-141,432,930  Indirect
Tetraphase Pharmaceuticals, Inc
Director
NasdaqGS:TTPH
(historical quotes, profile, other insiders)
2-Oct-14890,146  Indirect
XenoPort, Inc.
Director
NasdaqGS:XNPT
(historical quotes, profile, other insiders)
14-May-14
3-Jun-14
8,899
   489,496
498,395
  Direct
  Indirect  
  Total

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
27-Oct-14 *121,760PRTO Option Exercise at $4.60 per share.
(Cost of $560,096)
27-Oct-14 *56,038PRTO Sale at $10 per share.
(Proceeds of $560,380)
27-Oct-14 *1,167,208PRTO Acquisition (Non Open Market)
27-Oct-14 *200,000PRTO Purchase at $10 per share.
(Cost of $2,000,000)
2-Oct-14 *105,588TTPH Automatic Sale at $20.72 - $21.02 per share.
(Proceeds of about $2,204,000)
1-Oct-14 *142,146TTPH Automatic Sale at $20.41 - $20.89 per share.
(Proceeds of about $2,935,000)
30-Sep-14 *56,618TTPH Automatic Sale at $20.17 per share.
(Proceeds of $1,141,985)
29-Sep-14 *95,648TTPH Automatic Sale at $20.19 per share.
(Proceeds of $1,931,133)
17-Sep-14 *77,000TTPH Automatic Sale at $17.36 per share.
(Proceeds of $1,336,720)
16-Sep-14 *67,356TTPH Automatic Sale at $17.03 per share.
(Proceeds of $1,147,072)
12-Sep-14 *53,544TTPH Automatic Sale at $17.01 per share.
(Proceeds of $910,783)
11-Sep-14 *2,100TTPH Automatic Sale at $17 per share.
(Proceeds of $35,700)
8-Sep-14 *4,473TTPH Automatic Sale at $15.01 per share.
(Proceeds of $67,139)
5-Sep-14 *12,227TTPH Automatic Sale at $15.01 per share.
(Proceeds of $183,527)
4-Sep-14 *41,200TTPH Automatic Sale at $15.06 per share.
(Proceeds of $620,472)
3-Sep-14 *142,100TTPH Automatic Sale at $15.04 per share.
(Proceeds of $2,137,184)
23-Jun-14 *47,184TTPH Automatic Sale at $13.77 per share.
(Proceeds of $649,723)
20-Jun-14 *82,716TTPH Automatic Sale at $13.65 per share.
(Proceeds of $1,129,073)
19-Jun-14 *70,100TTPH Automatic Sale at $13.08 per share.
(Proceeds of $916,908)
3-Jun-14 *12,500XNPT Purchase at $3.93 per share.
(Cost of $49,125)
23-May-14 *9,500XNPT Purchase at $3.72 per share.
(Cost of $35,340)
22-May-14 *5,500XNPT Purchase at $3.75 per share.
(Cost of $20,625)
14-May-14 *4,493TTPH Disposition (Non Open Market) at $0 per share.
14-May-14 *3,006TTPH Acquisition (Non Open Market) at $0 per share.
14-May-14 5,000XNPT Option Exercise at $0 per share.
12-Mar-14 *4,493TTPH Acquisition (Non Open Market) at $0 per share.
12-Mar-14 *300,000TTPH Disposition (Non Open Market) at $0 per share.
20-Feb-14 *150,000CNCE Purchase at $14 per share.
(Cost of $2,100,000)
20-Feb-14 *1,026,548CNCE Acquisition (Non Open Market)
12-Feb-14 *32,372CNCE Statement of Ownership
17-Dec-13 *2,287,951MAKO Disposition (Non Open Market) at $30 per share.
(Value of $68,638,530)
16-May-13 5,000XNPT Option Exercise at $0 per share.
25-Mar-13 *1,498,789TTPH Acquisition (Non Open Market)
25-Mar-13 *681,012TTPH Purchase at $7 per share.
(Cost of $4,767,084)
19-Mar-13 *10,345TTPH Statement of Ownership
    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)



EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?